Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Alan So
Your Marketing Team Can Superdrive AI Adoption - If You Let Them
According to a recent survey of over 1,900 senior marketers by Dentsu, 52% felt that “building trust with consumers in an era of misinformation” was one of the greatest obstacles getting in the way of their business objectives. Though survey-takers spanned various industries, I suspect those working with B2B tech companies feel this even more profoundly. Because right now, you can’t be a B2B tech brand without also being an AI company, and headlines regarding AI can feel overwhelmingly negative.
Summary of changes in the 2025 Canadian Urological Association/Canadian Urologic Oncology Group guideline on metastatic castration-resistant prostate cancer
Saad, F., & So, A. I. (2025). Summary of changes in the 2025 Canadian Urological Association/Canadian Urologic Oncology Group guideline on metastatic castration-resistant prostate cancer. Canadian Urological Association Journal , 19 (8), 228–9. https://doi.org/10.5489/cuaj.9359 You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.
Summary of changes in the 2025 Canadian Urological Association-Canadian Urologic Oncology Group Guideline on metastatic castration-naive and castration-sensitive prostate cancer | Canadian Urological Association Journal
So, A. I., & Saad, F. (2025). Summary of changes in the 2025 Canadian Urological Association–Canadian Urologic Oncology Group Guideline on metastatic castration-naive and castration-sensitive prostate cancer. Canadian Urological Association Journal , 19 (5), E140–1. https://doi.org/10.5489/cuaj.9228 You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.
Analgesic efficacy of rectus sheath catheter is non‐inferior to thoracic epidural catheter
Letter to the Editor Analgesic efficacy of rectus sheath catheter is non-inferior to thoracic epidural catheter Raymond Tang, Raymond Tang Department of Anesthesia, University of British Columbia, Vancouver, British Columbia, Canada Search for more papers by this authorEdmund Charles Paul Chedgy, Edmund Charles Paul Chedgy Department of Anesthesia, University of British Columbia, Vancouver, British Columbia, Canada Department of Urology, University Hospital Southampton, Hampshire, UK Search...
UPDATE: Canadian Urological Association-Canadian Urologic Oncology Group guideline: Metastatic castration-naive and castration-sensitive prostate cancer (Summary of changes)
License You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.
UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies (Summary of changes)
License You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.
UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis: Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging - Summary of changes | Canadian U
Mason, R. J. ., Marzouk, K. ., Finelli, A. ., Saad, F., So, A. I., Violette, P. D. ., Breau, R. H., & Rendon, R. A. . (2022). UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis: Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging – Summary of changes. Canadian Urological Association Journal, 16(4). https://doi.org/10.5489/cuaj.7832
Targeting the androgen receptor axis at the time of RP
So, A. I. (2021). Targeting the androgen receptor axis at the time of RP. Canadian Urological Association Journal , 15 (8), 280. https://doi.org/10.5489/cuaj.7494 You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.
Safety data – GnRH Analogues, focus on CVD risk profile - UROONCO Prostate Cancer
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies - Executive summary
Kokorovic, A., So, A. I., Serag, H., French, C., Hamilton, R. J., Izard, J. P., Nayak, J. G., Pouliot, F., Saad, F., Shayegan, B., Aprikian, A., & Rendon, R. A. (2021). Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies – Executive summary. Canadian Urological Association Journal, 15(6), 159-61. https://doi.org/10.5489/cuaj.7357
Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.
Canadian Urological Association best practice report: Diagnosis and management of sporadic angiomyolipomas
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.
Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer
So, A. I., Chi, K. N., Danielson, B., Fleshner, N. E., Kapoor, A., Niazi, T., Pouliot, F., Rendon, R. A., Shayegan, B., Sridhar, S., Vigneault, E., & Saad, F. (2019). Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer. Canadian Urological Association Journal, 14(2), 17-23. https://doi.org/10.5489/cuaj.6384
Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer | Canadian Urological Association Journal
Danielson, B., Saad, F., So, A., Morgan, S., Hamilton, R., Malone, S., Park-Wyllie, L., Zardan, A., & Shayegan, B. (2019). Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer. Canadian Urological Association Journal, 13(10). https://doi.org/10.5489/cuaj.5600
The burden of symptomatic skeletal events in castrate-resistant prostate cancer patients with bone metastases at three Canadian uro-oncology centres
Introduction: Metastatic bone disease in castrate-resistant prostate cancer (CRPC) carries risks of significant morbidity, including symptomatic skeletal events. We estimated the healthcare resource costs of managing skeletal events.
Aquablation among novice users in Canada: A WATER II subpopulation analysis
Introduction: Surgical management options for lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) associated with prostates of small to moderate volume (80 cc), many of these options are neither safe nor effective. Recently, Aquablation (PROCEPT BioRobotics, Inc., U.S.), a precise ultrasound-guided, robotically executed prostatic ablative procedure, has become available with U.S. Food and Drug Administration approval.
Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians
Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians Androgen-deprivation therapy (ADT) is a standard of care in the treatment of advanced prostate cancer; however, testosterone monitoring practices for men undergoing ADT vary across Canada.
The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?
License You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Alan
Contact Alan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack